EPIC GENETICS LIMITED

Company Registration Number:
14522190 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2023

Period of accounts

Start date: 04 December 2022

End date: 31 December 2023

EPIC GENETICS LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2023

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 11

EPIC GENETICS LIMITED

Company Information

for the Period Ended 31 December 2023




Director: anthony pemberton
Registered office: 111
Watersplash Road
Shepperton
Surrey
GBR
TW17 0EE
Company Registration Number: 14522190 (England and Wales)

EPIC GENETICS LIMITED

Directors' Report Period Ended 31 December 2023

The directors present their report with the financial statements of the company for the period ended 31 December 2023

Principal Activities

Epigenetic testing and coaching.

Directors

The director(s) shown below were appointed to the company during the period
anthony pemberton
04 December 2022

This report was approved by the board of directors on 23 February 2024
And Signed On Behalf Of The Board By:

Name: anthony pemberton
Status: Director

EPIC GENETICS LIMITED

Profit and Loss Account

for the Period Ended 31 December 2023


Notes
13 months to
31 Dec 2023
£
Gross turnover (not including turnover from inside OPW engagements) 16,608
Gross turnover from inside OPW engagements 0
Deductions from gross turnover from inside OPW engagements ( 0 )
Cost of sales ( 26,829 )
Gross Profit or (Loss) ( 10,221 )
Operating Profit or (Loss) ( 10,221 )
Profit or (Loss) Before Tax ( 10,221 )
Profit or (Loss) for Period ( 10,221 )

The notes form part of these financial statements

EPIC GENETICS LIMITED

Balance sheet

As at 31 December 2023


Notes
13 months to
31 Dec 2023
£
Fixed assets
Intangible assets: 4 0
Tangible assets: 5 700
Total fixed assets: 700
Current assets
Stocks: 1,606
Debtors: 6 0
Cash at bank and in hand: 345
Total current assets: 1,951
Net current assets (liabilities): 1,951
Total assets less current liabilities: 2,651
Total net assets (liabilities): 2,651

The notes form part of these financial statements

EPIC GENETICS LIMITED

Balance sheet continued

As at 31 December 2023


Notes
13 months to
31 Dec 2023
£
Capital and reserves
Called up share capital: 2,651
Shareholders funds: 2,651

For the year ending 31 December 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 23 February 2024
And Signed On Behalf Of The Board By:

Name: anthony pemberton
Status: Director

The notes form part of these financial statements

EPIC GENETICS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

EPIC GENETICS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

  • 2. Employees

    13 months to
    31 Dec 2023
    Average number of employees during the period 1

EPIC GENETICS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

  • 3. Off balance sheet disclosure

    No

EPIC GENETICS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

4. Intangible assets

Other Total
Cost £ £
Additions - -
Disposals - -
Revaluations - -
Transfers - -
At 31 December 2023 - -
Amortisation
Charge for year - -
On disposals - -
Other adjustments - -
Amortisation at 31 December 2023 - -
Net book value
Net book value at 31 December 2023 - -

none

EPIC GENETICS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

5. Tangible assets

Office equipment Total
Cost £ £
Additions 700 700
Disposals - -
Revaluations - -
Transfers - -
At 31 December 2023 700 700
Depreciation
Charge for year - -
On disposals - -
Other adjustments - -
At 31 December 2023 - -
Net book value
At 31 December 2023 700 700

No depreciation for equipment

EPIC GENETICS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

6. Debtors

13 months to
31 Dec 2023
£
Trade debtors 0
Prepayments and accrued income 0
Other debtors 0
Total 0
Debtors due after more than one year: 0

na